Every day our bodies are exposed to millions of pathogens, through contact, ingestion and the air we breathe in. The innate immune system is the first layer of defence against this assault. Kirsty Harper of Envigo explains that a thorough knowledge of the highly complex immune system can enable it to be harnessed to develop immune-therapeutics and a translational approach to pre-clinical safety assessment studies is essential for effective clinical stage development.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2018/12/Harnessing-the-immune-system-for-immuno-therapeutics.pdf” width=”100%” height=”900px” style=”border:0;”]